ALNY

311.10

1.18% -3.70

시간 외 거래: 312.20 1.10 +0.35%

Alnylam Pharmaceuticals Inc (ALNY)

개요 뉴스 가격 이력 옵션 체인 Financials ALNY 왜 하락? 토론 예측

전일 마감가:

$314.80

열려 있는:

$316.42

하루 거래량:

648.36K

Relative Volume:

0.44

시가총액:

$41.26B

수익:

$3.71B

순이익/손실:

$313.75M

주가수익비율:

137.83

EPS:

2.2571

순현금흐름:

$465.38M

1주 성능:

-1.93%

1개월 성능:

-8.33%

6개월 성능:

-31.41%

1년 성능:

+22.75%

1일 변동 폭

$309.73

$317.61

1주일 범위

$309.73

$326.96

52주 변동 폭

$205.87

$495.55

Alnylam Pharmaceuticals Inc Stock (ALNY) Company Profile

명칭

Alnylam Pharmaceuticals Inc

부문

Healthcare (1114)

산업

Biotechnology (621)

전화

(617) 551-8200

주소

675 WEST KENDALL STREET, CAMBRIDGE, MA

직원

2,500

트위터

@alnylam

다음 수익 날짜

2026-02-12

최신 SEC 제출 서류

ALNY's Discussions on Twitter

Compare ALNY vs VRTX, REGN, ARGX, ONC

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ALNY Alnylam Pharmaceuticals Inc	311.10	41.75B	3.71B	313.75M	465.38M	2.2571
VRTX Vertex Pharmaceuticals Inc	458.05	114.72B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	737.45	78.67B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	684.50	42.38B	4.16B	1.29B	734.26M	19.59
ONC Beone Medicines Ltd Adr	282.72	31.33B	5.36B	287.73M	924.18M	2.5229

Alnylam Pharmaceuticals Inc Stock (ALNY) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-16	다운그레이드	Jefferies	Buy → Hold
2026-01-28	재개	Barclays	Overweight
2026-01-07	재개	Oppenheimer	Outperform
2025-08-04	업그레이드	Oppenheimer	Perform → Outperform
2025-08-04	업그레이드	Wolfe Research	Underperform → Peer Perform
2025-07-30	재개	Raymond James	Outperform
2025-07-21	개시	Truist	Buy
2025-03-31	개시	Redburn Atlantic	Buy
2025-03-24	업그레이드	JP Morgan	Neutral → Overweight
2024-11-12	다운그레이드	Wolfe Research	Peer Perform → Underperform
2024-10-16	개시	Scotiabank	Sector Outperform
2024-08-16	업그레이드	Goldman	Neutral → Buy
2024-02-16	다운그레이드	Goldman	Buy → Neutral
2024-02-15	개시	Wolfe Research	Peer Perform
2023-12-08	개시	Wells Fargo	Equal Weight
2023-10-11	다운그레이드	Oppenheimer	Outperform → Perform
2023-09-29	개시	Raymond James	Outperform
2023-05-05	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-26	개시	SMBC Nikko	Neutral
2023-03-21	개시	Bernstein	Outperform
2023-01-18	개시	Canaccord Genuity	Buy
2022-09-09	재개	Morgan Stanley	Equal-Weight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-06-27	다운그레이드	Guggenheim	Buy → Neutral
2022-06-07	개시	William Blair	Outperform
2022-04-25	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2022-03-01	개시	Citigroup	Buy
2022-02-03	업그레이드	Guggenheim	Neutral → Buy
2022-01-03	업그레이드	Piper Sandler	Neutral → Overweight
2021-11-22	업그레이드	Goldman	Neutral → Buy
2021-11-22	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2021-11-01	업그레이드	Oppenheimer	Perform → Outperform
2021-10-04	업그레이드	UBS	Neutral → Buy
2021-08-04	다운그레이드	Piper Sandler	Overweight → Neutral
2021-02-22	다운그레이드	Guggenheim	Buy → Neutral
2021-02-12	다운그레이드	Citigroup	Buy → Neutral
2021-02-12	재확인	H.C. Wainwright	Buy
2021-01-25	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-09-30	재개	Berenberg	Hold
2020-09-08	개시	Citigroup	Buy
2020-08-11	다운그레이드	Oppenheimer	Outperform → Perform
2020-05-13	개시	RBC Capital Mkts	Sector Perform
2020-05-07	다운그레이드	JP Morgan	Overweight → Neutral
2020-04-24	재개	Evercore ISI	Outperform
2020-03-19	개시	Berenberg	Buy
2019-12-19	재확인	Chardan Capital Markets	Buy
2019-11-20	개시	Oppenheimer	Outperform
2019-11-13	개시	BofA/Merrill	Buy
2019-05-23	재개	Goldman	Neutral
2019-04-12	개시	Evercore ISI	Outperform
2019-03-06	업그레이드	Evercore ISI	In-line → Outperform
2019-03-05	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2019-01-23	개시	UBS	Neutral
2018-10-01	개시	Cantor Fitzgerald	Overweight
2018-08-13	재확인	Stifel	Buy
2018-08-07	업그레이드	Stifel	Hold → Buy
2018-05-04	재확인	Stifel	Hold
2018-03-28	개시	Evercore ISI	In-line

모두보기

Alnylam Pharmaceuticals Inc 주식(ALNY)의 최신 뉴스

10:33 AM

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead? - TradingView

10:33 AM

09:50 AM

Novartis acquisition spin-off pioneers RNA therapeutics for the heart - Pharma Voice

09:50 AM

06:00 AM

Groupama Asset Managment Purchases 2,483,697 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

06:00 AM

04:27 AM

CIBC Private Wealth Group LLC Reduces Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

04:27 AM

Mar 18, 2026

Canaccord Genuity maintains buy rating on Alnylam Pharmaceuticals, Inc. (ALNY) stock - MSN

Mar 18, 2026

Alnylam’s research pact worth up to $1.1B sends Tenaya higher - MSN

Mar 18, 2026

Alnylam’s Cardiovascular RNAi Collaboration With Tenaya Might Change The Case For Investing In ALNY - simplywall.st

Mar 18, 2026

Mar 17, 2026

Alnylam Pharmaceuticals Q2 2025 Earnings Preview - MSN

Mar 17, 2026

Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years - Benzinga

Mar 17, 2026

The $3B Biotech With Two Shots On Goal - Benzinga

Mar 17, 2026

Linden Advisors LP Makes New $6.55 Million Investment in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Mar 17, 2026

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Short Interest Down 12.8% in February - MarketBeat

Mar 17, 2026

Brevan Howard Capital Management LP Buys Shares of 6,170 Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Mar 17, 2026

Jefferies downgrades Alnylam Pharmaceuticals (ALNY) - MSN

Mar 17, 2026

California Public Employees Retirement System Buys 18,060 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Mar 17, 2026

Bamco Inc. NY Acquires New Shares in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Mar 17, 2026

(ALNY) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Mar 17, 2026

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After New Tenaya Cardiovascular Partnership - simplywall.st

Mar 17, 2026

Mar 16, 2026

JP Morgan Maintains Alnylam Pharmaceuticals (ALNY) Overweight Recommendation - MSN

Mar 16, 2026

ALNY Downgraded by Jefferies with Price Target Significantly Low - GuruFocus

Mar 16, 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Earns Hold Rating from Jefferies Financial Group - MarketBeat

Mar 16, 2026

Jain Global LLC Purchases 61,316 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

Mar 16, 2026

Here Are Monday’s Top Wall Street Analyst Research Calls: Alnylam Pharmaceuticals, Circle Internet, Fifth Third Bancorp, Intuit, ServiceNow, Qualcomm, Trade Desk, and More - 24/7 Wall St.

Mar 16, 2026

Patisiran Comprehensive Forecast on the Accelerating Market - openPR.com

Mar 16, 2026

Mar 15, 2026

6,888 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Acquired by Capula Management Ltd - MarketBeat

Mar 15, 2026